Kuroda K, Horita Y, Sakane M, Okumoto S, Katoh M, Saitoh Y
First Dept. of Surgery, Kobe University School of Medicine.
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2859-62.
Hepatic artery and portal vein infusion of adriamycin (ADM) to normal rabbit and the experimental liver metastasis model of VX2 tumor were discussed in this study. The concentration of ADM in the peripheral blood, liver, myocardium, lung of normal rabbit and metastatic tumor were measured in the HPLC method. There was no difference between arterial infusion and portal infusion in the normal rabbits. In the metastatic tumor, one hour after the infusion, concentration of ADM showed no difference between arterial and portal infusion, but two and three hours later, the concentration was significantly higher after portal infusion than arterial infusion. It was suspected that portal infusion would be more effective for liver metastasis. The number of tumor nodules for estimation of the anti-tumor effect on metastatic models was decreased significantly after arterial and portal infusion compared with the controls, but there was no statistical difference between arterial and portal infusion.
本研究探讨了对正常兔及VX2肿瘤实验性肝转移模型进行肝动脉和门静脉阿霉素(ADM)灌注的情况。采用高效液相色谱法测定正常兔外周血、肝脏、心肌、肺及转移瘤中阿霉素的浓度。正常兔动脉灌注和门静脉灌注之间无差异。在转移瘤中,灌注后1小时,动脉灌注和门静脉灌注的阿霉素浓度无差异,但2小时和3小时后,门静脉灌注后的浓度显著高于动脉灌注。推测门静脉灌注对肝转移可能更有效。与对照组相比,动脉灌注和门静脉灌注后,用于评估对转移模型抗肿瘤效果的肿瘤结节数量显著减少,但动脉灌注和门静脉灌注之间无统计学差异。